Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

Código QR

Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

Background/purpose: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the curative therapy for acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS), but advanced age with multiple comorbidities limits the eligibility for allo-HSCT. We conducted a retrospectiv...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sheng-Hsuan Chien, Ming Yao, Chi-Cheng Li, Ping-Ying Chang, Ming-Sun Yu, Cih-En Huang, Tran-Der Tan, Cheng-Hsien Lin, Su-Peng Yeh, Sin-syue Li, Po-Nan Wang, Yi-Chang Liu, Jyh-Pyng Gau
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Acute leukemia Myelodysplastic syndrome Elderly adult Allogeneic hematopoietic stem cell transplantation Charlson comorbidity index Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/861f791a07d1452aa885f018ffe5effc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Correlating complications of transurethral complications of prostate using the Charlson’s Comorbidity Index
por: Aditya Kumar, et al.
Publicado: (2016)

Comparison of Indexes to Measure Comorbidity Burden and Predict All-Cause Mortality in Rheumatoid Arthritis
por: Yun-Ju Huang, et al.
Publicado: (2021)

Hematopoietic stem cell transplantation: clinical use and perspectives
por: Barriga,Francisco, et al.
Publicado: (2012)

Analysis of predictors of mortality after surgical and non-surgical management in proximal humerus fractures
por: Alejandro Garcia-Reza, et al.
Publicado: (2021)

Risk factors for late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: analysis of 227 cases
por: XIONG Yiying, et al.
Publicado: (2021)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
por: Takahashi,Hiroshi, et al.
Publicado: (2015)

Efficacy and safety of posaconazole in prevention of invasive fungal infections during allogeneic hematopoietic stem cell transplantation: a single-center retrospective analysis
por: ZHANG Yanfang, et al.
Publicado: (2021)

Iron chelation therapy improves hematopoiesis in patients with hematological malignancy after hematopoietic stem cell transplantation
por: ZENG Cong, et al.
Publicado: (2021)

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Yan-Ruide Li, et al.
Publicado: (2021)

Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era
por: Sanghee Hong, et al.
Publicado: (2021)

Improvement of hematopoietic stem cell transplantation in the targeted therapy era
por: ZHANG Xi, et al.
Publicado: (2021)

Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use
por: Ivan Pasic, et al.
Publicado: (2021)

Transitory response of a myelodysplastic syndrome with deletion of chromosome 5q to thalidomide. Report of one case
por: Palacios-Campos,Adriana, et al.
Publicado: (2020)

Effect of Amnion-Wrapped Allogenic Nerve Bridging on Peripheral Nerve Injury
por: Zhang,Yan-Ru, et al.
Publicado: (2013)

Thoracic Purpura in a Patient With Myelodysplastic Syndrome
por: Nuno Gomes, et al.
Publicado: (2021)

Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
por: Delaney Wolfe, et al.
Publicado: (2021)

Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
por: Yi-Chang Liu, et al.
Publicado: (2021)

From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review
por: Thibault Comont, et al.
Publicado: (2021)

Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine
por: Carlo Pescia, et al.
Publicado: (2021)

Managing myelodysplastic symptoms in elderly patients
por: R Ria, et al.
Publicado: (2009)

Managing myelodysplastic syndromes in very old patients: a teaching case report
por: Niscola P, et al.
Publicado: (2013)

Association Between Charlson Comorbidity Index and Community-Acquired Pressure Injury in Older Acute Inpatients in a Chinese Tertiary Hospital
por: Zhang Z, et al.
Publicado: (2021)

Histiocytoid Sweet’s syndrome in a patient with myelodysplastic syndrome: report and review of the literature
por: Michael M. Shalaby, et al.
Publicado: (2016)

Femtosecond Laser-assisted Allogenic Additive Stromal Keratoplasty With or Without Excimer Laser Donor Keratomileusis for Management of Keratoconus
por: Mohammad-Reza Jafarinasab, et al.
Publicado: (2021)

Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Donata Backhaus, et al.
Publicado: (2021)

Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
por: Ritchie EK
Publicado: (2012)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA; A SINGLE CENTRE EXPERIENCE
por: Tariq Azam Khattak, et al.
Publicado: (2021)

Comparative assessment of conventional chromosomal analysis and fluorescence in situ hybridization in the evaluation of suspected myelodysplastic syndromes: A single institution experience
por: Denyo Adjoa Zakhia, et al.
Publicado: (2019)

TP53 in Myelodysplastic Syndromes
por: Yan Jiang, et al.
Publicado: (2021)

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
por: Paul J. Martin, et al.
Publicado: (2021)

DIAGNOSTIC UTILITY OF SERUM LACTATE DEHYDROGENASE LEVELS (LDL) IN DIFFERENTIATING MEGALOBLASTIC ANEMIA FROM MYELODYSPLASTIC SYNDROMES IN PAKISTAN
por: Faraz Ali Rana, et al.
Publicado: (2021)

Immune response to allogeneic equine mesenchymal stromal cells
por: J. Lacy Kamm, et al.
Publicado: (2021)

Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
por: HE Yundi, et al.
Publicado: (2021)

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
por: Wei C, et al.
Publicado: (2021)

Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation
por: Elizabeth R. Duke, et al.
Publicado: (2021)

Development of comorbidity-adapted exercise protocols for patients with knee osteoarthritis
por: de Rooij M, et al.
Publicado: (2014)

The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous
por: Jia-ming Chen, et al.
Publicado: (2021)

Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients
por: Parisi S, et al.
Publicado: (2021)

ACTIVATION OF T. GONDII INFECTION AFTER ALLOGENEIC TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS: DEPENDENCE ON TIME OF TRANSPLANTATION AND SEROLOGICAL STATUS OF THE PATIENTS
por: A. B. Chukhlovin, et al.
Publicado: (2015)

Editorial: The Role of Hematopoietic Progenitors in Immune Regulation and Memory
por: Flora Zavala, et al.
Publicado: (2021)